Difficulty: Medium
Average Score: 86%
Testbank
A nurse is providing patient education for a patient with peptic ulcer disease secondary to chronic nonsteroidal anti-inflammatory drug (NSAID) use. The patient has recently been prescribed misoprostol (Cytotec). What would the nurse be most accurate in informing the patient about the drug?
Correct answer
C
Rationale
C: It protects the stomachs lining.
Misoprostol is a prostaglandin E1 analog that helps protect the gastric mucosa by increasing the production of mucus and bicarbonate, as well as promoting epithelial cell regeneration. This protective effect is particularly important for patients with peptic ulcer disease caused by NSAID use, as these medications can compromise the stomach lining.
A: It reduces the stomachs volume of hydrochloric acid.
While misoprostol can have some effect on gastric acid secretion, its primary function is not to reduce acid volume but rather to protect the gastric lining, making this statement misleading in the context of peptic ulcer disease.
B: It increases the speed of gastric emptying.
Misoprostol does not primarily affect gastric emptying speed; instead, it focuses on mucosal protection. Thus, this option does not align with the main therapeutic action needed for a patient with peptic ulcer disease.
D: It increases lower esophageal sphincter pressure.
This option is unrelated to the primary function of misoprostol. The drug is not indicated for improving lower esophageal sphincter pressure, which is not a focus in the management of peptic ulcer disease caused by NSAID use.
Misoprostol is a prostaglandin E1 analog that helps protect the gastric mucosa by increasing the production of mucus and bicarbonate, as well as promoting epithelial cell regeneration. This protective effect is particularly important for patients with peptic ulcer disease caused by NSAID use, as these medications can compromise the stomach lining.
A: It reduces the stomachs volume of hydrochloric acid.
While misoprostol can have some effect on gastric acid secretion, its primary function is not to reduce acid volume but rather to protect the gastric lining, making this statement misleading in the context of peptic ulcer disease.
B: It increases the speed of gastric emptying.
Misoprostol does not primarily affect gastric emptying speed; instead, it focuses on mucosal protection. Thus, this option does not align with the main therapeutic action needed for a patient with peptic ulcer disease.
D: It increases lower esophageal sphincter pressure.
This option is unrelated to the primary function of misoprostol. The drug is not indicated for improving lower esophageal sphincter pressure, which is not a focus in the management of peptic ulcer disease caused by NSAID use.